BTMD logo

biote Corp. Stock Price

NasdaqGM:BTMD Community·US$130.1m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

BTMD Share Price Performance

US$2.87
-2.39 (-45.44%)
52.2% undervalued intrinsic discount
US$6.00
Fair Value
US$2.87
-2.39 (-45.44%)
59.0% undervalued intrinsic discount
US$7.00
Fair Value
Price US$2.87
AnalystHighTarget US$7.00
AnalystConsensusTarget US$4.88
AnalystLowTarget US$4.00

BTMD Community Narratives

AnalystHighTarget·
Fair Value US$6 52.2% undervalued intrinsic discount

Digital Health Expansion Will Elevate Preventative Care Despite Regulatory Hurdles

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$4.88 41.2% undervalued intrinsic discount

Commercial Reorganization And E-Commerce Expansion Will Drive Mixed Future Prospects

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AnalystLowTarget·
Fair Value US$3.5 18.0% undervalued intrinsic discount

Regulatory Risks Will Limit Hormone Therapy But Telemedicine Will Help

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent BTMD News & Updates

Restructuring At Biote Will Drive Greater Growth And Profitability

Sep 10

Results: biote Corp. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 09
Results: biote Corp. Exceeded Expectations And The Consensus Has Updated Its Estimates

Benign Growth For biote Corp. (NASDAQ:BTMD) Underpins Stock's 28% Plummet

Aug 08
Benign Growth For biote Corp. (NASDAQ:BTMD) Underpins Stock's 28% Plummet

biote Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 10
biote Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Market Participants Recognise biote Corp.'s (NASDAQ:BTMD) Earnings

May 09
Market Participants Recognise biote Corp.'s (NASDAQ:BTMD) Earnings

biote Corp. Key Details

US$199.1m

Revenue

US$55.8m

Cost of Revenue

US$143.3m

Gross Profit

US$112.0m

Other Expenses

US$31.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.99
Gross Margin
71.97%
Net Profit Margin
15.73%
Debt/Equity Ratio
-132.8%

biote Corp. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Undervalued with moderate risk.

5 Risks
3 Rewards

About BTMD

Founded
2012
Employees
217
CEO
Bret Christensen
WebsiteView website
www.biote.com

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.8%
  • 3 Months: 8.3%
  • 1 Year: 17.8%
  • Year to Date: 15.4%
Over the last 7 days, the market has remained flat, although notably the Utilities sector gained 3.1% in that time. Meanwhile, the market is actually up 18% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›